Financhill
Back

Bicara Therapeutics Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Buy
58

BCAX
Bicara Therapeutics

Last Price:
$12.91
Seasonality Move:
--
Sell
50

RYTM
Rhythm Pharmaceuticals

Last Price:
$57.44
Seasonality Move:
54.9%
Buy
58
Bicara Therapeutics (BCAX) is a Buy

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $14.19. The Score for BCAX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Rhythm Pharmaceuticals (RYTM) is a Sell

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $58.97. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $14.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $58.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 55.19 Buy
Chaikin Money Flow: 315501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11 - 14.7) Buy
Bollinger Bands (100): (11.57 - 15.81) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.04 Buy
Relative Strength Index (14 RSI): 46.88 Sell
Chaikin Money Flow: 27337 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.61 - 64.05) Sell
Bollinger Bands (100): (52.9 - 60.74) Buy

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.51 Buy
20-day SMA: 13.55 Buy
50-day SMA: 13.08 Buy
200-day SMA: 0 Buy
8-day EMA: 13.5 Buy
20-day EMA: 13.38 Buy
50-day EMA: 13.28 Buy
200-day EMA: 11.72 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.08 Sell
20-day SMA: 62.15 Sell
50-day SMA: 56.78 Buy
200-day SMA: 54.27 Buy
8-day EMA: 61.17 Sell
20-day EMA: 61 Sell
50-day EMA: 58.76 Buy
200-day EMA: 53.68 Buy

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.00 per share, and a decrease next year of $0.52 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):